The pharmaceutical field is seeing a significant shift in blood sugar care with the arrival of GLP-1 skin applications. These revolutionary methods offer a likely simple alternative to subcutaneous injections for individuals living with diabetes mellitus type 2. By bypassing the need for frequent injections, GLP-1 skin devices promise to improve pa